Varex Imaging (NASDAQ:VREX) Director Jay Kunkel Sells 8,121 Shares of Stock

Varex Imaging (NASDAQ:VREX) Director Jay Kunkel sold 8,121 shares of the stock in a transaction on Monday, September 14th. The stock was sold at an average price of $18.48, for a total value of $150,076.08. Following the completion of the sale, the director owned 15,329 shares in the company, valued at approximately $283,279.92. The trade was a 34.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Varex Imaging Stock Up 0.1%

NASDAQ:VREX opened at $18.47 on Wednesday. Varex Imaging has a twelve month low of $9.09 and a twelve month high of $18.63. The company has a market cap of $777.59 million, a price-to-earnings ratio of 35.52 and a beta of 0.96. The stock has a fifty day simple moving average of $15.11 and a 200-day simple moving average of $12.40. The company has a current ratio of 3.38, a quick ratio of 1.53 and a debt-to-equity ratio of 0.64.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.10. The firm had revenue of $210.50 million for the quarter, compared to analysts’ expectations of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. Analysts anticipate that Varex Imaging will post 1.04 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on VREX. Wall Street Zen upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Sidoti reiterated a “neutral” rating and issued a $19.00 price target on shares of Varex Imaging in a report on Monday, August 10th. B. Riley Financial cut Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. CJS Securities cut Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 17th. Finally, Oppenheimer downgraded Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 10th. Seven equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $16.88.

Institutional Investors Weigh In On Varex Imaging

Large investors have recently modified their holdings of the business. SG Americas Securities LLC grew its stake in Varex Imaging by 4.4% during the 1st quarter. SG Americas Securities LLC now owns 30,202 shares of the company’s stock valued at $320,000 after purchasing an additional 1,272 shares during the last quarter. Glenmede Trust Co. NA raised its stake in shares of Varex Imaging by 15.5% in the first quarter. Glenmede Trust Co. NA now owns 14,202 shares of the company’s stock worth $151,000 after purchasing an additional 1,909 shares during the last quarter. Hsbc Holdings PLC raised its stake in shares of Varex Imaging by 5.2% in the fourth quarter. Hsbc Holdings PLC now owns 46,283 shares of the company’s stock worth $544,000 after purchasing an additional 2,298 shares during the last quarter. Rockefeller Capital Management L.P. acquired a new stake in shares of Varex Imaging during the fourth quarter worth about $27,000. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of Varex Imaging during the second quarter worth about $32,000.

Varex Imaging Company Profile

Varex Imaging Corporation (NASDAQ: VREX) develops and manufactures X-ray imaging components used by medical, industrial and security equipment manufacturers. Its products are incorporated into systems that support diagnostic imaging, radiation therapy, inspection and threat detection.

The company’s portfolio includes X-ray tubes, digital image detectors, high-voltage generators, image-processing software and other imaging subsystems. These products are used in applications such as computed tomography, radiography, fluoroscopy, mammography, dental and veterinary imaging, as well as industrial non-destructive testing and security screening.

Varex Imaging was established as an independent public company in 2017 through a spin-off from Varian Medical Systems.